Conquer Cancer Foundation
Conquer Cancer Foundation is ASCO's 501(c)(3) philanthropic arm, funding early-career oncologists through grants and awards distributed at the annual ASCO meeting and supporting global cancer research across 96 countries.
- Company typePrivate
- Founded1999
- HeadquartersAlexandria, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Conquer Cancer Foundation does
The Conquer Cancer Foundation is the official philanthropic arm of the American Society of Clinical Oncology (ASCO), operating as a 501(c)(3) public charity headquartered in Alexandria, Virginia. Founded in 1999, the foundation's mission is to accelerate breakthroughs in cancer research by funding early-career oncologists and physician-scientists through a portfolio of grants and awards, including Young Investigator Awards, Career Development Awards, and disease-specific endowed awards. Grants are awarded annually in conjunction with the ASCO Annual Meeting, where more than $11.7 million was distributed across 480+ awards in 2026 to recipients representing 45–96 countries (figures vary by source and time horizon).
The foundation generates no product revenue; its income streams consist entirely of philanthropic contributions from individual donors, corporate sponsors, and partner foundations. Revenue channels include online donations, monthly giving (Conquerors Community), tribute gifts, workplace matching programs, peer-to-peer fundraising (Unite and Conquer), and major-donor cultivation of pharmaceutical companies and high-net-worth individuals. Named top donors contributing $1 million or more annually include AstraZeneca, Genentech/Roche, Johnson & Johnson, Novartis, Novocure, the Breast Cancer Research Foundation, and the Norman and Ruth Rales Foundation, among others. Notable partnerships in 2026 include co-funded awards with the Parker Institute for Cancer Immunotherapy and The Dynami Foundation.
Commercially, the organization operates a small staff (11–50 employees) and distributes content and donor engagement through a multi-channel platform spanning the Your Stories podcast, social media, email, content marketing, and large-scale annual events. Strategic positioning leverages ASCO's global brand authority within oncology to differentiate Conquer Cancer from other cancer charities; cumulative fundraising since inception exceeds $500 million. Leadership is provided by Board Chair Dr. Howard A. Burris III, with governance under ASCO's oversight structure.
Conquer Cancer Foundation firmographics
Firmographics- Name
- Conquer Cancer Foundation
- Legal name
- Conquer Cancer Foundation of the American Society of Clinical Oncology
- Website
- https://conquer.org
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Conquer Cancer Foundation is ASCO's 501(c)(3) philanthropic arm, funding early-career oncologists through grants and awards distributed at the annual ASCO meeting and supporting global cancer research across 96 countries.
- Ownership category
- akta.pro rank
Conquer Cancer Foundation industry classification
Industry- Product category
- Cancer Research Nonprofit Foundation
- NAICS
- Grantmaking Foundations (813211), Voluntary Health Organizations (813212), Grantmaking and Giving Services (8132)
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- Health & Medical Research Grantmaking Foundations (BPAGAKAL)
- akta.pro secondary industries
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA), Corporate Foundations & CSR Grantmaking (BPAGAKAC), Research & Science Grantmaking Foundations (BPAGAKAI)
Keywords
Where Conquer Cancer Foundation is headquartered
LocationHeadquarters
- HQ city
- Alexandria
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Conquer Cancer Foundation business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Others, Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Individual Donations: Individual donors contribute through online donations, monthly giving programs (Conquerors Community), tribute gifts (in honor/memory), and peer-to-peer fundraising campaigns.
- Corporate Sponsorship: Corporate partners including AstraZeneca, Genentech/Roche, Johnson & Johnson, Novartis, Novocure, and others provide major donor support. Top donors contribute $1 million or more annually.
- Foundation Grants: Other foundations such as The Dynami Foundation and The Parker Institute for Cancer Immunotherapy co-fund research awards and grants through partnership agreements.
- Workplace Matching Gifts: Employers match employee charitable contributions, allowing donors to multiply their giving impact.
Go-to-market motion2 records
Distribution channels6 records
Marketing channels8 records
Conquer Cancer Foundation product offering
Product offeringCore offering
Conquer Cancer Foundation, the ASCO Foundation, is a 501(c)(3) nonprofit that raises philanthropic funds and distributes them as grants and awards to support cancer research, primarily funding early-career oncologists and physician-scientists. In 2026 alone, the foundation awarded more than $11.7 million through over 480 grants and awards at the ASCO Annual Meeting. It also operates donor engagement programs, a peer-to-peer fundraising platform, and a patient/researcher podcast.
Product overview
Conquer Cancer Foundation, the ASCO Foundation, operates as a cancer research funding organization rather than a traditional technology product company. Its core offerings consist of grant and award programs that fund early-career oncologists and cancer researchers, supplemented by the Your Stories podcast platform featuring patient and researcher narratives. Additional services include the Unite and Conquer peer-to-peer fundraising platform, donation processing, workplace giving programs, and educational content. The organization does not offer a unified software platform with modular components but rather a collection of interconnected programs supporting its mission to accelerate breakthroughs in lifesaving cancer research.
Differentiator
Problem solved
Functional benefit
Brands
- Your Stories: A podcast featuring candid conversations between people conquering cancer, including patients, family members, doctors, and researchers.
Products and services
- Grants & Awards Programs
Quantifiable outcome
- More than $500M+ raised in support of Research, Education, and Quality programs
- +5 more outcomes
Companies that use Conquer Cancer Foundation
Customer profileNamed customers12 records
Segments5 records
Ideal customer profiles4 records
Conquer Cancer Foundation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Conquer Cancer Foundation partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- The Dynami FoundationcorePartnership to support the 2026 Conquer Cancer – Dynami Foundation Young Investigator Award providing $50,000 grant to Dr. Shoshana Rosenzweig for invasive lobular breast cancer research. Part of Dynami Foundation's broader commitment including $250,000 catalytic grant to Lobular American Research Consortium and $3M+ across 20+ lobular breast cancer projects.
- Parker Institute for Cancer ImmunotherapycoreCollaboration with ASCO to co-fund a Conquer Cancer Endowed Young Investigator Award providing $50,000 annual grant to support early-career oncologists transitioning from training to faculty positions. Designed to promote high-quality immunotherapy research with inaugural recipient to be announced at 2026 ASCO Annual Meeting.
- Lobular American Research ConsortiumminorRecipient of $250,000 catalytic grant from Dynami Foundation for ILC research, working with Conquer Cancer on the Young Investigator Award program.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
Conquer Cancer Foundation competitors and assessment
Company assessmentDirect peers
- Stand Up To Cancer: Fundraising collaborative funding innovative 'Dream Team' translational cancer research. Comparable mission, entertainment-industry donor base, and emphasis on practice-changing breakthroughs.
- V Foundation for Cancer Research: Founded in memory of Jim Valvano, V Foundation funds translational and clinical cancer research via competitive grants to investigators at NCI-designated centers. Closely comparable grant-making model and donor-driven structure.
- Cancer Research Institute: Nonprofit dedicated to funding immunotherapy and immuno-oncology research through grants and investigator awards. Directly comparable on early-career funding model and disease-specific focus.
- Pancreatic Cancer Action Network (PanCAN): Patient-advocacy and research-funding nonprofit focused on pancreatic cancer, awarding research grants and advocating for federal research funding. Comparable on patient-driven philanthropy and grant programs.
- Lustgarten Foundation: Largest private funder of pancreatic cancer research, supporting both basic and translational research grants. Comparable disease-specific focus and donor-driven grantmaking.
- Damon Runyon Cancer Research Foundation: Funds high-impact early-career cancer researchers through prestigious Damon Runyon Fellowships. Directly comparable on funding early-stage physician-scientists and producing breakthrough research.
- American Cancer Society: Largest U.S. nonprofit funder of cancer research, supporting early-career investigators and broad oncology research programs. Directly comparable mission and donor base to Conquer Cancer.
- Breast Cancer Research Foundation (BCRF): Nation's largest dedicated breast cancer funder, awarding grants to researchers globally. Overlaps with Conquer Cancer on disease-specific research funding and major-donor philanthropy; BCRF is also listed as a top donor to Conquer Cancer.
Broad incumbents
- American Association for Cancer Research (AACR): Largest professional society for cancer researchers globally, with its own foundation funding cancer research. Broad incumbent with overlapping mission, scientific community access, and grants portfolio.
- National Cancer Institute (NCI/NIH): Federal government's principal agency for cancer research and training, awarding billions annually in grants. Broad incumbent establishing the funding environment within which Conquer Cancer's early-career awards operate.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Conquer Cancer Foundation social profiles
Digital presenceConquer Cancer Foundation compliance and trust
Trust signalCompliance4 records
Conquer Cancer Foundation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Conquer Cancer Foundation leadership team
Management profileNumber of profiles
Profiles2 records
Conquer Cancer Foundation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Conquer Cancer Foundation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Conquer Cancer Foundation
What does Conquer Cancer Foundation do?
Conquer Cancer Foundation, the ASCO Foundation, is a 501(c)(3) nonprofit that raises philanthropic funds and distributes them as grants and awards to support cancer research, primarily funding early-career oncologists and physician-scientists. In 2026 alone, the foundation awarded more than $11.7 million through over 480 grants and awards at the ASCO Annual Meeting. It also operates donor engagement programs, a peer-to-peer fundraising platform, and a patient/researcher podcast.
Is Conquer Cancer Foundation a public or private company?
Conquer Cancer Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Conquer Cancer Foundation founded?
Conquer Cancer Foundation was founded in 1999. It employs 11 to 50 people.
Where is Conquer Cancer Foundation based?
Conquer Cancer Foundation is headquartered in Alexandria, United States, in the North America region.
How does Conquer Cancer Foundation make money?
Four revenue lines are on record. Individual Donations are the primary driver. The others are corporate Sponsorship, foundation Grants and workplace Matching Gifts.
Who are Conquer Cancer Foundation's main competitors?
Direct peers on record are Stand Up To Cancer, V Foundation for Cancer Research, Cancer Research Institute, Pancreatic Cancer Action Network (PanCAN), Lustgarten Foundation, Damon Runyon Cancer Research Foundation, American Cancer Society and Breast Cancer Research Foundation (BCRF). Broad incumbents are American Association for Cancer Research (AACR) and National Cancer Institute (NCI/NIH).
Does Conquer Cancer Foundation have an API?
No public API is recorded for Conquer Cancer Foundation.
What industry is Conquer Cancer Foundation in?
Conquer Cancer Foundation's product category is Cancer Research Nonprofit Foundation. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813211 and its SIC code is 8600.